NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,433,000 | -88.0% | 447,820 | -85.8% | 0.34% | -88.0% |
| Q2 2022 | $11,970,000 | +2120.8% | 3,150,000 | +3050.0% | 2.87% | +2108.5% |
| Q1 2022 | $539,000 | -80.4% | 100,000 | -51.0% | 0.13% | -78.8% |
| Q4 2021 | $2,755,000 | -69.6% | 203,900 | -59.6% | 0.61% | -71.0% |
| Q3 2021 | $9,064,000 | -76.6% | 504,691 | -76.2% | 2.11% | -40.7% |
| Q3 2019 | $38,707,000 | – | 2,125,000 | – | 3.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |